With more people dying each year and many spending their final days in institutions, researchers argue that wider access to palliative care could offer a more humane and cost-effective alternative, write ROX MIDDLETON, LIAM SHAW and MIRIAM GAUNTLETT
THE National Institute for Health and Care Excellence (Nice) has published its draft guidelines on the treatment of depression — the first change in 12 years.
In this it differentiates between what it calls mild, moderate and severe depression, with a so-called “menu” of treatment options available, to tempt healthcare providers and patients away from anti-depressants.
It would be hard to argue against increasing choice. But still there are a few points that remain a concern, such as how decisions are made as to what group a patient belongs to, along with the pressure on services. More widely, why are the terms reactive and clinical not being used and why are these changes being made now?
When privatisation is already so deeply embedded in the NHS, we can’t just blindly argue for ‘more funding’ to solve its problems, explain ESTHER GILES, NICO CSERGO, BRIAN GIBBONS and RATHI GUHADASAN



